Physician profile
Jeevan Kumar
NPI 1366820078
$11,630.94
in general payments reported to CMS, 2019-2025
41 companies · $3,501 in 2025
The $3,501 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.04 · 2022: $2,022 · 2023: $2,898 · 2024: $3,125 · 2025: $3,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,524.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,982.74 | 2022-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Impulse Dynamics (USA) INC. | $869.02 | 2023-2025 | Optimizer, Optimizer |
| Esperion Therapeutics, INC. | $845.85 | 2021-2025 | Nexletol, Nexlizet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $799.26 | 2022-2025 | Lifevest |
| Boston Scientific Corporation | $592.32 | 2023-2025 | Watchman Flx, Watchman Access System, Watchman |
| Alnylam Pharmaceuticals INC. | $574.31 | 2022-2025 | Onpattro |
| Edwards Lifesciences Corporation | $474.52 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $471.30 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $412.67 | 2021-2025 | |
| Pfizer INC. | $355.61 | 2022-2025 | |
| Cvrx, INC. | $344.96 | 2022-2025 | Barostim Neo System |
| Novo Nordisk INC | $330.60 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $299.03 | 2021-2025 | Verquvo, Capvaxive |
| Kiniksa Pharmaceuticals International, Plc | $272.45 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $267.35 | 2025 | Attruby |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $265.50 | 2022-2025 | Farxiga, Wainua, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.36 | 2022-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $201.54 | 2022-2025 | Evkeeza |
| Amgen INC. | $196.89 | 2022-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $172.88 | 2022-2023 | Xarelto |
| Scpharmaceuticals INC. | $172.20 | 2023-2025 | |
| Kiniksa Pharmaceuticals, Ltd. | $155.33 | 2022-2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $152.80 | 2022-2025 | Assure Wcd |
| Abiomed | $140.19 | 2024-2025 | Impella |
| Abbott Laboratories | $138.76 | 2022-2025 | Jot Dx |
| Teva Pharmaceuticals USA, INC. | $136.40 | 2025 | Austedo Xr |
| Silk Road Medical, INC. | $116.48 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Sanofi-Aventis U.S. LLC | $93.58 | 2022-2023 | |
| Medtronic, INC. | $71.60 | 2024 | Symplicity G3, Venaseal |
| Recor Medical INC | $68.36 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Amarin Pharma, INC. | $64.65 | 2021-2023 | |
| Irhythm Technologies, INC. | $60.56 | 2022-2023 | Zio Xt Patch |
| Baxter Healthcare | $58.09 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $55.77 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $40.31 | 2025 | |
| Astellas Pharma US INC | $23.84 | 2023 | Lexiscan |
| Inspire Medical Systems, INC. | $23.81 | 2024 | Inspire |
| Heartflow, INC. | $22.29 | 2024 | |
| Daiichi Sankyo INC. | $21.09 | 2023 | Injectafer |
| Actelion Pharmaceuticals US, INC. | $20.19 | 2024 | Uptravi, Opsumit |
| Corcept Therapeutics | $15.48 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeevan Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.